Login / Signup

Hyperprogressive Disease After Pembrolizumab Treatment in Advanced Epstein-Barr Virus-Associated Gastric Adenocarcinoma With ERBB2 Amplification.

Sarah WatsonJoanna CyrtaMarine LefevreJulien Masliah PlanchonChristophe LouvetVincent ServoisPauline VaflardFrançois Clément BidardIvan BiecheEmilie Soularue
Published in: JCO precision oncology (2022)
Keyphrases
  • epstein barr virus
  • diffuse large b cell lymphoma
  • squamous cell carcinoma
  • tyrosine kinase
  • nucleic acid
  • radiation therapy
  • combination therapy
  • replacement therapy